This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/04/16 - 3:59:45 PM ET (BATS BZX Real-time Price)
Div Yield: --
ATRC Day's Range
ATRC 52 Week Range
ATRC Business Summary
AtriCure, Inc., a medical device company, provides atrial fibrillation solutions to hospitals and medical centers in the United States and internationally.View ATRC
AtriCure Inc - ATRC - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates AtriCure Inc as a
Sell with a ratings score of D+.
Report Snippet: We rate ATRICURE INC (ATRC) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.